Silvia Martin Lluesma | Co-director of Advanced Cell Therapies Program
VHIO

Silvia Martin Lluesma is a pioneering leader in the field of advanced cell therapies, currently serving as the Co-director of the Advanced Cell Therapies Program at the Vall d'Hebron Institute of Oncology (VHIO), as Tenured Professor in Cell & Gene Therapy at Universidad CEU San Pablo (USP-CEU), and initiating a new Advanced Therapies project at the Institute of Health Research at FJD (IIS-FJD). With a strong background in biomedical research and a passion for translating scientific discoveries into clinical applications, Silvia is at the forefront of developing cutting-edge cell and gene therapies for cancer and other diseases.

Silvia's expertise lies in harnessing the power of the immune system to target and eliminate cancer cells, with a focus on TILs, CAR-T cell therapies and other innovative approaches. Her work at VHIO involves collaborating with multidisciplinary teams to design and implement clinical trials that bring novel cell therapies from the lab to the bedside, offering new hope to patients with challenging medical conditions.

With a track record of impactful research publications and presentations at top scientific conferences, Silvia is recognized as a thought leader in the field of advanced therapies. Her dedication to advancing the field through collaboration, innovation, and patient-centric care makes her a sought-after speaker and expert in the rapidly evolving landscape of cell and gene therapies.

Silvia's commitment to improving patient outcomes and pushing the boundaries of what is possible in the field of cell therapies makes her a valuable asset to the scientific community and a driving force behind the development of next-generation treatments. As a speaker at Advanced Therapies UK 2027, Silvia will share her insights and expertise, inspiring others to join her in advancing the future of medicine through transformative cell and gene therapies.